Your session is about to expire
← Back to Search
Focused Ultrasound Thalamotomy for Epilepsy and Anxiety
Study Summary
This trial will study whether a non-invasive brain procedure can help people with epilepsy who haven't responded to medication, and whether it can also reduce anxiety.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently on dialysis.I have had 3 or more seizures a month in the last 3 months.I haven't taken blood thinners or drugs that increase bleeding risk close to my ultrasound procedure.I have had bleeding in my brain before.I have a history of unusual bleeding or blood clotting issues.I have moderate to severe anxiety.I have not had a stroke or multiple strokes in the last six months.My scalp has significant thinning and heals poorly.My cancer can be seen on scans.My epilepsy hasn't improved despite trying at least two different medications.I have a neurological disorder, but it's not epilepsy.I have epilepsy that developed after a herpes infection.My medication doses, including for epilepsy or mental health, have been stable for 3 months.I have a neurodegenerative disease like Alzheimer's or Parkinson's.I have fewer than 3 seizures a month.I have been diagnosed with a type of generalized epilepsy.I am legally unable to make my own decisions.I have undergone stereotactic ablation before.I can stay still on my back for up to 4 hours.My blood tests show I might be at risk of bleeding during or after surgery.I cannot communicate with my doctor or their team.I have a stable heart condition without recent severe issues.I do not have any uncontrolled infections or life-threatening diseases.I experience seizures that start in one area and can spread.I experience symptoms like headaches or vision changes.I cannot or will not keep my epilepsy drug dose stable for 3 months after treatment.I have had surgery to sever the connection between my brain's hemispheres.I have a brain tumor, including any that have spread from elsewhere.
- Group 1: Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What outcomes is the research hoping to attain?
"This 12-month study seeks to measure the impact of its intervention on patient anxiety. Secondary objectives include gauging quality of life changes, evaluating patients' ability to perform an fMRI task before and after a procedure, and assessing modifications in self-reported stress levels over time."
Is the patient demographic for this trial limited to individuals aged 55 or younger?
"The age limits for this clinical trial are 18 to 65 years. There is a total of 248 and 589 studies available, respectively, concerning those below and above the specified age range."
Is it still possible to join the experiment as a participant?
"Clinicaltrials.gov indicates that this research is no longer open to new applicants, having first been posted on December 1st 2022 and last updated October 26th 2022. However, 857 other trials are presently recruiting participants."
Do I fulfill the criteria to enter into this research program?
"With this pharmaceutical trial, 10 adults aged 18 - 65 are being admitted to participate. Furthermore, these individuals should be able to provide a seizure diary for 3 months before and after the study as well their care provider's involvement; have focal onset seizures with or without primary generalization that occur at least three times per month in the last quarter prior to enrolment; must demonstrate medically refractory epilepsy due to two anti-epileptic drug failures; maintain an unchanging dosage of medications (anti-epileptics and psychotropics included) over the course of 3 months leading up to enrollment date; and display moderate-severe anxiety"
Has the FDA endorsed Magnetic Resonance Imaging-guided Focused Ultrasound Ablation (MRgFUSA) for implementation?
"MRgFUSA receives a score of 1 on the scale, signifying that its safety and efficacy have been established to some degree in initial studies."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger